Home LiteratureArticle Details
PMID: 16398680 Published · ppublish English

Malignant perivascular epithelioid cell tumor of the colon: report of a case with molecular analysis.

Pathology international ·Vol. 56 ·No. 1 ·2006-03-31

Yamamoto Hidetaka, Oda Yoshinao, Yao Takashi, Oiwa Toshio, Kobayashi Chikashi, Tamiya Sadafumi, Kawaguchi Ken-ichi, Hino Okio, Tsuneyoshi Masazumi

Abstract

Perivascular epithelioid cell tumor (PEComa) is a rare mesenchymal neoplasm, and malignant cases are extremely rare. A case of malignant PEComa arising in the colon is described herein. The patient was a 43-year-old Japanese woman without a history of tuberous sclerosis complex. The tumor occurred in the abdominal cavity attached to the serosal side of the descending colon. Histologically, the tumor consisted of sheets or closely packed nests of epithelioid cells with clear or eosinophilic cytoplasms. The tumor cells were positive for HMB-45 but negative for S-100 protein and cytokeratins by immunohistochemical staining. Ki-67 labeling index was 2.9%. Peritoneal dissemination of tumor occurred at 20 months and the patient died of tumor at 38 months after the initial operation. This was considered to be a case of malignant PEComa, based on the histological and clinical features. Tumor cells showed overexpression of cyclin D1 but lacked the loss of heterozygosity of the TSC1 and TSC2 genes. The result suggests that the overexpression of cyclin D1 may play an important role in the tumorigenesis of PEComa. Because PEComas can behave in an aggressive manner, careful follow up is warranted.

Article Info
Journal
Pathology international
Abbr.
Pathol Int
Published
2006-03-31
Indexed
2006-01-09
Updated
2015-11-19
Language
English
Country/Region
Australia
NLM ID
9431380
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]